Background:Maternal intrauterine infection/inflammation represents the major etiology of preterm delivery and the leading cause of neonatal mortality and morbidity. The aim of this study was to investigate the anti-inflammatory properties of thioredoxin-1 in vivo and its potential ability to attenuate the rate of inflammation-induced preterm delivery. Methods: Two intraperitoneal injections of lipopolysaccharide from Escherichia coli were administered in pregnant mice on gestational day 15, with a 3-h interval between the injections. From either 1 h before or 1 h after the first lipopolysaccharide injection, mice received three intravenous injections of either recombinant human thioredoxin-1, ovalbumin, or vehicle, with a 3-h interval between injections. results: Intraperitoneal injection of lipopolysaccharide induced a rise of tumor necrosis factor-α, interferon-γ, monocyte chemotactic protein 1, and interleukin-6 in maternal serum levels and provoked preterm delivery. Recombinant human thoredoxin-1 prevented the rise in these proinflammatory cytokine levels. After the inflammatory challenge, placentas exhibited severe maternal vascular dilatation and congestion and a marked decidual neutrophil activation. These placental pathological findings were ameliorated by recombinant human thioredoxin-1, and the rate of inflammation-induced preterm delivery was attenuated. conclusion: Thioredoxin-1 may thus represent a novel effective treatment to delay inflammation-induced preterm delivery.t he estimated number of preterm births (defined as birth before gestational week 37) worldwide was 15 million in 2010 (11.1%) (1). Preterm birth is the most frequent cause of infant mortality and leads to one million deaths per year. Premature infants face increased risk of neonatal complications, such as intraventricular hemorrhage, bronchopulmonary dysplasia, retinopathy, and necrotizing enterocolitis as well as increased risk of adult-onset obesity, diabetes, and hypertension (2,3).Intrauterine infection or inflammation caused by various bacteria, including Escherichia coli, Gardnerella vaginalis, anaerobic bacteria, and genital mycoplasmas, can lead to preterm birth (4,5). Animal models of bacterial componentinduced preterm birth have been established (6,7).Thioredoxin-1 (TRX), originally cloned as a soluble factor called adult T-cell leukemia-derived factor (8), is one of the most important molecules controlling the redox regulation system and contains a redox-active disulfide/dithiol within the conserved active site sequence Cys 32 -Gly-Pro-Cys 35 (ref. (9)). TRX has a pivotal role in scavenging reactive oxygen species (ROS) with peroxiredoxins, and thus, it prevents apoptosis of various cells (10). Moreover, circulating TRX inhibits neutrophil infiltration into the sites of inflammation by blocking the adhesion of lipopolysaccharide (LPS)-stimulated neutrophils on endothelial cells (11). Overexpression of human TRX in transgenic mice induced resistance to harmful conditions, including thioacetamide-or LPS-induced acute hepati...